Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-12-072435
Filing Date
2012-10-31
Accepted
2012-10-31 06:09:26
Documents
2
Period of Report
2012-10-31

Document Format Files

Seq Description Document Type Size
1 NOVARTIS TO START CONSTRUCTION OF NEW BIOTECHNOLOGY FACILITY IN SINGAPORE. a12-25682_16k.htm 6-K 48152
2 GRAPHIC g256821bci001.jpg GRAPHIC 2217
  Complete submission text file 0001104659-12-072435.txt   52306
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 121169561
SIC: 2834 Pharmaceutical Preparations